May 27, 2026 01:00AM
Apr 23, 2026 11:45AM
Mar 18, 2026 12:45PM
Mar 2, 2026 11:45AM
Feb 23, 2026 11:45AM
Feb 18, 2026 11:45AM
Feb 12, 2026 04:05PM Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
Feb 12, 2026 04:05PM
Feb 9, 2026 01:00AM
Feb 9, 2026 01:00AM
Jan 19, 2026 01:00AM
Dec 8, 2025 11:45AM
Nov 25, 2025 11:45AM
Nov 3, 2025 11:53AM Median Technologies adds Lion Point Capital founder to board
Nov 3, 2025 11:45AM
Oct 23, 2025 11:45AM
Sep 22, 2025 11:45AM
Jul 23, 2025 01:00AM
Jul 21, 2025 04:00PM
Jul 11, 2025 12:46PM
Jul 1, 2025 12:09PM Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS
May 14, 2025 01:00AM
May 12, 2025 11:45AM
Apr 29, 2025 11:45AM
Apr 24, 2025 11:45AM
Mar 31, 2025 12:28PM
Feb 24, 2025 11:45AM
Feb 3, 2025 01:00AM Median Technologies: eyonis™ Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions
Jan 31, 2025 02:00AM
Jan 24, 2025 02:00AM
Nov 26, 2024 11:45AM
Nov 7, 2024 12:19PM
Oct 30, 2024 12:45PM
Oct 24, 2024 11:45AM
Sep 11, 2024 11:45AM Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024
Sep 4, 2024 11:45AM
Aug 29, 2024 11:45AM
Aug 6, 2024 11:45AM
May 29, 2024 11:45AM
Apr 25, 2024 11:45AM
Jan 29, 2024 11:45AM
Jan 17, 2024 11:45AM Median Technologies Reports Excellent Results from Its Independent Verification Study
Nov 26, 2023 11:00AM
Oct 19, 2023 11:45AM
Oct 17, 2023 11:45AM
Jul 17, 2023 11:45AM
Jul 12, 2023 11:40AM
Apr 20, 2023 11:45AM
Feb 28, 2023 11:45AM Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2
Feb 27, 2023 11:45AM

323,895 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All